The US healthcare market is valued at $2.8 trillion, with diagnostic testing directing 70% of all spend (1, 2). To put that into perspective, 13% of US gross domestic product (GDP), or 13 cents of every dollar, is guided by what occurs at the tip of a needle, urine cup, or specimen vial. FactorOriginal Article
You may also like
Ariane de Ganck
Jasper Therapeutics merges with Kira Pharmaceuticals
Lilly to acquire AtaiBeckley in deal worth $2.8bn
Camena Bioscience appoints Gregory McGuinness as CEO
New €25 Million BioReliance Testing Facility Opens...
StockWatch: Lilly’s Up-to-$3.8B Deal for AtaiBeckley...
About the author
David Miller
a pharmacist, a tech enthusiastic, who explored the Internet to gather all latest information pharma, biotech, healthcare and other related industries.
